Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Reau

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Gastroenterology & Hepatology|March 15, 2017
Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on DialysisJenny Sauk, Donald M Jensen, Smruti R Mohanty, et al.
The American Journal of Gastroenterology|November 11, 2010
Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis CNancy Reau, Rohit Satoskar, Helen Te, et al.
Pharmacoeconomics|May 28, 2025
Health Care Resource Utilization and Costs Associated with US Medicaid Sobriety Restrictions on Direct-Acting Antivirals for Hepatitis C Virus: A Retrospective Claims Database AnalysisMichelle T Martin, Krithika Rajagopalan, Dilip Makhija, et al.
Current Medical Research and Opinion|May 28, 2020
Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysisTarik Asselah, Stefan Zeuzem, Nancy Reau, et al.
Therapeutic Advances in Gastroenterology|September 14, 2012
Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver diseaseArchita P Desai, Nancy Reau, K Gautham Reddy, et al.
Gastroenterology & Hepatology|September 29, 2023
Improving the Management of Hepatorenal Syndrome-Acute Kidney Injury Using an Updated Guidance and a New Treatment ParadigmMichelle Loftus, Robert S Brown, Neveen S El-Farra, et al.
Gastroenterology & Hepatology|March 6, 2024
Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment RegimensNikolaos T Pyrsopoulos, David Bernstein, Marcelo Kugelmas, et al.
Journal of Clinical Gastroenterology|October 9, 2013
Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver diseaseArchita P Desai, Rohit Satoskar, Anoop Appannagari, et al.
Clinical Transplantation|May 5, 2012
Use of immune function test in monitoring immunosuppression in liver transplant recipientsHelen S Te, Kathleen A Dasgupta, Dingcai Cao, et al.
Clinical Liver Disease|December 25, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Gastroenterology & Hepatology|March 15, 2017
Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on DialysisJenny Sauk, Donald M Jensen, Smruti R Mohanty, et al.
The American Journal of Gastroenterology|November 11, 2010
Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis CNancy Reau, Rohit Satoskar, Helen Te, et al.
Pharmacoeconomics|May 28, 2025
Health Care Resource Utilization and Costs Associated with US Medicaid Sobriety Restrictions on Direct-Acting Antivirals for Hepatitis C Virus: A Retrospective Claims Database AnalysisMichelle T Martin, Krithika Rajagopalan, Dilip Makhija, et al.
Current Medical Research and Opinion|May 28, 2020
Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysisTarik Asselah, Stefan Zeuzem, Nancy Reau, et al.
Therapeutic Advances in Gastroenterology|September 14, 2012
Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver diseaseArchita P Desai, Nancy Reau, K Gautham Reddy, et al.
Gastroenterology & Hepatology|September 29, 2023
Improving the Management of Hepatorenal Syndrome-Acute Kidney Injury Using an Updated Guidance and a New Treatment ParadigmMichelle Loftus, Robert S Brown, Neveen S El-Farra, et al.
Gastroenterology & Hepatology|March 6, 2024
Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment RegimensNikolaos T Pyrsopoulos, David Bernstein, Marcelo Kugelmas, et al.
Journal of Clinical Gastroenterology|October 9, 2013
Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver diseaseArchita P Desai, Rohit Satoskar, Anoop Appannagari, et al.
Clinical Transplantation|May 5, 2012
Use of immune function test in monitoring immunosuppression in liver transplant recipientsHelen S Te, Kathleen A Dasgupta, Dingcai Cao, et al.
Clinical Liver Disease|December 25, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Pageof 10